Jane Street Group LLC Lowers Stake in Chemed Co. (NYSE:CHE)

Jane Street Group LLC lowered its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 56.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,245 shares of the company's stock after selling 6,913 shares during the quarter. Jane Street Group LLC's holdings in Chemed were worth $3,152,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. American National Bank & Trust purchased a new stake in shares of Chemed in the 3rd quarter worth about $61,000. GAMMA Investing LLC increased its stake in shares of Chemed by 60.5% during the third quarter. GAMMA Investing LLC now owns 138 shares of the company's stock valued at $83,000 after purchasing an additional 52 shares in the last quarter. Quarry LP lifted its holdings in shares of Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company's stock valued at $103,000 after purchasing an additional 166 shares during the last quarter. Sound Income Strategies LLC purchased a new stake in shares of Chemed in the 3rd quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC increased its position in Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after buying an additional 324 shares in the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Stock Up 0.3 %

Shares of NYSE CHE traded up $1.37 during trading on Friday, reaching $523.16. 241,923 shares of the company traded hands, compared to its average volume of 87,427. The firm has a 50 day simple moving average of $564.38 and a 200-day simple moving average of $563.99. Chemed Co. has a 52-week low of $516.91 and a 52-week high of $654.62. The stock has a market capitalization of $7.87 billion, a PE ratio of 26.44, a P/E/G ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the company earned $5.32 EPS. As a group, research analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend was Monday, November 18th. Chemed's dividend payout ratio is 10.11%.

Analyst Upgrades and Downgrades

Several research firms have commented on CHE. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their target price on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.

Insiders Place Their Bets

In other news, Director George J. Walsh III sold 400 shares of the company's stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 11.61 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,132 shares of company stock valued at $3,003,502. Insiders own 3.32% of the company's stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.